Nuclear Medicine studies are performed at the 55 Spindrift Drive office in Williamsville by technologists that are NMTCB and/or ARRT certified in Nuclear Medicine. Windsong has two GE Millennium MG dual head SPECT (Single Photon Emission Computerized Tomography) nuclear cameras. In addition to routine nuclear imaging, we perform several specialized nuclear procedures. This includes thyroid therapy for hyperthyroidism and Quadramet® therapy for pain management in patients with bone metastases, and radioimmunotherapy for treatment of non-Hodgkin’s lymphoma.
Windsong is also offering a new FDA approved treatment for prostate cancer. Xofigo® (Radium 223 dichloride) is a new therapy used to treat prostate cancer that is resistant to other medical and surgical treatments that seek to lower testosterone levels in patients whose disease has spread to the bones. To learn more, click here.
Somatostatin-type receptor binding peptide radiopharmaceuticals are approved for the detection of neuroendocrine tumors. Octreoscan has been utilized for the rapid detection and localization of neuroendocrine tumors, primary or metastatic, which are often missed by conventional imaging procedures. Windsong is now offering Ga-68, NETSPOT® , used to localize endocrine tumors for staging and restaging, however is not used for diagnosing. This exam has improved lesion detection compared to Ostreoscan. The Ga68 Dotatate utilized in the NETSPOT® PET radiotracer offers as much as 30% better lesion detection and has 100 times higher affinity for neuroendocrine tumor receptor sites than the traditional nuclear medicine imaging with Ostreoscan. NIH research showed that Ga68 Dotatate PET can change patient management in nearly 71% of patients with neuroendocrine tumors by providing more accurate and clinically relevant information.
ProstaScint® Imaging is one of the new offerings in nuclear medicine. The monoclonal antibody is used in the detection of recurrent prostate cancer with lymph node involvement. CT images of the pelvis are fused with the nuclear images to precisely pinpoint any areas that are suspicious for cancer.
Another new diagnostic tool added more recently is DaTscan. This agent assist in the evaluation of adult patients with suspected Parkinsonian syndromes. has shown efficacy for detecting degeneration of the dopaminergic nigrostriatal pathway, allowing better separation of patients with essential tremor from those with presynaptic Parkinsonian syndromes, as well as differentiating between some causes of Parkinsonism.
|Bone Marrow Scans||Lung Scans (ventilation or perfusion)|
|Bone Scans||Lymphosintigraphy (melanoma)|
|Breast Lymphoscintography||Meckel’s Diverticulum|
|Cardiac First Pass Study||Octreoscan (now offering NETSPOT)|
|Cardiac Gated-Blood Pool||Parathyroid|
|Gallium Scan- Tumor/Infection||Renal Scan (Lasix/captopril)|
|Gastric Emptying||Salivary Gland|
|Hemangioma-Hepatic Blood Pool||Tc99 White Cell Label (HMPAO)|
|Hepatobiliary (HIDA)||Techetium Thyroid Imaging|
|I-131 Whole Body Scan||Testicular Flow & Scan|
|Liver/Spleen Scan||Thyroid Uptake and Scan|
|Lung Quantitative Scan||WBC Localization|